Affordable Access

Oculo-respiratory syndrome after influenza vaccination: trends over four influenza seasons.

Authors
Type
Published Article
Journal
Vaccine
0264-410X
Publisher
Elsevier
Publication Date
Volume
23
Issue
28
Pages
3726–3732
Identifiers
PMID: 15882534
Source
Medline
License
Unknown

Abstract

ORS is an adverse event that occurred with both influenza vaccines used in Canada. Its frequency has declined substantially but is still present after 4 years. It constitutes a clinical entity distinct from anaphylactic allergy. Unlike anaphylaxis, ORS does not constitute an absolute contraindication to further doses.

Statistics

Seen <100 times